Catalyst Wire Dossier Catalyst Wire Dossier

Meningococcal ACWY Conjugate Vaccine

Meningococcal conjugate vaccine (serogroups A, C, W, Y) · Novartis
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Meningococcal ACWY Conjugate Vaccine, covering 2013-11-05 to 2018-09-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea [Phase 4]

See pricing